TAG ARCHIVES FOR clinical trials


In this week’s Research Ethics Roundup, hear the latest developments in the H5N1 debate, explore one doctor’s plan to minimize research misconduct, and learn about a recent study that found that some physicians may be doing research for all the wrong reasons.

Private-sector physicians run clinical trials mostly for the money, study finds: There has been a dramatic shift in those conducting most clinical trials from academically-affiliated physicians to private-sector physicians. A new study suggests this shift might be the result of big money’s influence over medical research, with many doctors thinking of trials as business ventures rather than scientific endeavors. <[...] Read more


Recent changes to clinical trial rules in Europe, an emerging controversy over Food and Drug Administration (FDA)-approved anemia drugs, and heated debate over the bird flu moratorium are all in the mix in this week’s Research Ethics Roundup.

Europe proposes revision of clinical trial rules: The European Commission has formally adopted proposals for new rules to replace the controversial Clinical Trials Directive. Experts predict that these changes will reduce some of the red tape that has resulted in bloated insurance costs and a reduction in the number of clinical trials being conducted in the EU since the inception of the directive.


Natasha Blakeney, MPH, is the training director of the Education Network to Advance Clinical Trials (ENACCT). Founded in 2004, ENACCT is dedicated to improving cancer care and research through clinical trials. In this piece, reprinted from ENACCT’s blog, Natasha shares her perspective on increasing enrollment of African Americans in cancer clinical trials.

The National Cancer Institute (NCI) recently released a video discussing African Americans and their participation in cancer clinical trials. The video highlights some of the well-known challenges affecting this study [...] Read more


By Elisa Hurley, PhD, Education Director at PRIM&R

In its December 15 report, the Presidential Commission for the Study of Bioethical Issues (the Commission) makes 14 recommendations to improve the current system of research protections.

One of the most nuanced and interesting parts of the Commission’s 193-page report is the [...] Read more


PRIM&R is pleased to introduce you to Barbara Brenner, author of the blog, Healthy Barbs. Barbara is the former executive director of Breast Cancer Action, and is living with amyotrophic lateral sclerosis (ALS). Having spent the past 15 years working on topics related to healthcare and illness, Barbara continues to stimulate critical conversations, and to encourage critical thinking about mainstream coverage of health care and medical issues. Today, we are pleased to share with you an excerpt from her blog:

Given the tiRead more